befiradol and its Impurities
Befiradol was discovered and developed by Pierre Fabre Médicament, a French pharmaceuticals company.It is an experimental drug being studied for the treatment of levodopa-induced dyskinesia. Reference standards of Befiradol API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.